Packaged into an engineered myotropic AAV capsid31 (MyoAAV4A), this triple vector combination restored the expression of FL-dystrophin and significantly improved muscle histopathology and function in a mouse model of DMD. The gene discussed is DMD; the disease is Duchenne muscular dystrophy.